Meeting Banner
Abstract #3899

Multi-Modal Imaging to Evaluate the Effects of Novel TLR Agonist Adjuvants in Vaccine-Mediated Tumor Immunity

Deepak K. Kadayakkara1, Hyam I. Levitsky1, Jeff W.M. Bulte2, 3

1Department of Oncology, Johns Hopkins School of Medicine, Baltimore, MD, United States; 2Cellular Imaging Section, Institute for Cell Engineering,, Johns Hopkins University, Baltimore, MD, United States; 3MRI research division, Johns Hopkins School of Medicine, Baltimore, MD, United States

We evaluated the effects of novel adjuvants in cancer vaccines using non-invasive imaging. Magnetovaccination and MRI were used to evaluate dendritic cell-mediated antigen capture and delivery to regional lymph nodes. The ensuing effector immune response mediated by T cells was studied by antigen-specific transgenic T cells and bioluminescence imaging. We show that, unexpectedly, adjuvants reduced antigen delivery to lymph nodes; however they induced a more effective tumor therapeutic response suggesting an alternate and hitherto unreported pathway for T cell expansion and accumulation.

Keywords

accumulation activation alone antigen audience axial back better bore caliper cancer capture cell cells cellular challenge clinicians coil colony combination consisting containing contrary counting dark decreased delivery described design developing division done draining effector encompassing engineering equipped evaluate evaluated evergreen expanding expansion expectations expressing flow footpad form goal harvested hind horizontal immune immunity immunological induce injected injecting institute intended irradiated johns labeled labeling like liver local long lymph mechanism mechanisms mediated medicine melanoma mice middle mixed modal model monitored month node nodes novel oncology optical patterns pixels platform positive potent predominant presence previously priming prior protection quantification quantified receptor reduced represent researchers respectively response responses role school scientists secreting section sections serially spleen stably stimulating strong studied subcutaneously suggesting supported system target therapeutic therapy threshold toll tracking treated tumor underlying understanding vaccinated vaccination vaccine vaccines validated validating volume